August 12, 2021

Bexson Biomedical Launches New Project, Applying Subcutaneous Delivery Technology To Multiple Psychedelic Compounds For Therapeutic Use

May 6, 2021

Labroots - Tweaked Version of Ketamine Could Solve the Opioid Crisis

April 29, 2021

Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation

March 1, 2021

Bexson Biomedical Hires Veteran Medical Device Development Leader, Will Focus On New Dosing & Delivery Solutions For Controlled Substances

February 2, 2021

Bexson Biomedical Raises $4.8 Million In Oversubscribed Series A

December 30, 2020

Bold Business: Battling Opioid Addiction With Technology – Breakthroughs in Wearable Devices

September 21, 2020

Stevanato Group And Bexson Biomedical Announce Collaboration To Develop A Customized Wearable Ketamine Delivery Device

September 19, 2020

Forbes - This Wearable Ketamine Device Could be the Future of Pain Management

August 4, 2020

Bexson Biomedical To Co-Host Virtual Ketamine Conference

June 30, 2020

Bexson Biomedical Adds Industry Leaders Bill Carson And Noah Craft As Advisors

Presentations

April 2021 -- Investor Presentation